Latest News about RPRX
Recent news which mentions RPRX
Stocks That Hit 52-Week Lows On Tuesday
February 28, 2023
From Benzinga
Insiders Selling TransMedics Group And 2 Other Stocks
February 28, 2023
From Benzinga
Top 5 Health Care Stocks That May Rocket Higher In Q1 2023
February 27, 2023
From Benzinga
From Benzinga
6 Stocks Warren Buffett Completely Exited in 2022
December 17, 2022
From Motley Fool
Looking Into Royalty Pharma's Return On Capital Employed
December 06, 2022
Tickers
RPRX
From Benzinga
From Motley Fool
From Benzinga
Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings
September 19, 2022
From Benzinga
From Motley Fool
These Are the 6 Stocks Warren Buffett Sold in the Second Quarter
August 20, 2022
From Motley Fool
From MarketWatch
Warren Buffett's Berkshire Takes Another Bite Of Apple, Boosts Energy Holdings, Cashes Out Of Verizon: What 13F Filing Reveals
August 16, 2022
From Benzinga
From Benzinga
Royalty Pharma plc (RPRX) Q2 2022 Earnings Call Transcript
August 05, 2022
Tickers
RPRX
From Motley Fool
From Motley Fool
From Benzinga
From Benzinga
This Analyst Thinks Blueprint Medicines' Non-Dilutive Funding 'Deflates M&A Speculation'
June 30, 2022
From Benzinga
Ipsen to acquire U.S.-based Epizyme for $247 million.
June 27, 2022
From MarketWatch
From Motley Fool
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.